M.H. Breuning

4.3k total citations
60 papers, 2.6k citations indexed

About

M.H. Breuning is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, M.H. Breuning has authored 60 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Genetics, 28 papers in Molecular Biology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in M.H. Breuning's work include Genetic Syndromes and Imprinting (13 papers), Genomic variations and chromosomal abnormalities (12 papers) and Genetic and Kidney Cyst Diseases (11 papers). M.H. Breuning is often cited by papers focused on Genetic Syndromes and Imprinting (13 papers), Genomic variations and chromosomal abnormalities (12 papers) and Genetic and Kidney Cyst Diseases (11 papers). M.H. Breuning collaborates with scholars based in Netherlands, United States and United Kingdom. M.H. Breuning's co-authors include Egbert Bakker, Hans F. A. Vasen, Sarina G. Kant, Jasper J. Saris, Juul Wijnen, Dorien J.M. Peters, Carli M.J. Tops, G.J.B. van Ommen, Johan T. den Dunnen and Hans Morreau and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

M.H. Breuning

59 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.H. Breuning Netherlands 29 1.3k 1.1k 408 314 281 60 2.6k
Monique Losekoot Netherlands 34 1.3k 1.0× 1.4k 1.2× 349 0.9× 226 0.7× 310 1.1× 125 3.1k
Israela Lerer Israel 29 972 0.8× 1.2k 1.1× 237 0.6× 188 0.6× 301 1.1× 77 2.5k
Dvorah Abeliovich Israel 31 1.4k 1.1× 1.5k 1.3× 229 0.6× 236 0.8× 450 1.6× 98 3.0k
Hans Kristian Ploos van Amstel Netherlands 30 1.3k 1.0× 1.6k 1.4× 210 0.5× 422 1.3× 148 0.5× 64 3.8k
Eamonn Sheridan United Kingdom 28 776 0.6× 1.2k 1.1× 455 1.1× 289 0.9× 623 2.2× 74 2.7k
Beyhan Tüysüz Türkiye 24 988 0.8× 1.4k 1.2× 127 0.3× 247 0.8× 171 0.6× 139 2.5k
Sigrid Tinschert Germany 31 985 0.8× 1.3k 1.2× 340 0.8× 205 0.7× 157 0.6× 94 3.1k
Ruthild G. Weber Germany 33 859 0.7× 2.0k 1.7× 407 1.0× 477 1.5× 212 0.8× 72 3.7k
Syed M. Jalal United States 28 1.0k 0.8× 1.3k 1.1× 317 0.8× 310 1.0× 314 1.1× 71 2.6k
Alexander A.L. Jorge Brazil 36 1.7k 1.3× 2.0k 1.8× 191 0.5× 251 0.8× 330 1.2× 185 3.8k

Countries citing papers authored by M.H. Breuning

Since Specialization
Citations

This map shows the geographic impact of M.H. Breuning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.H. Breuning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.H. Breuning more than expected).

Fields of papers citing papers by M.H. Breuning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.H. Breuning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.H. Breuning. The network helps show where M.H. Breuning may publish in the future.

Co-authorship network of co-authors of M.H. Breuning

This figure shows the co-authorship network connecting the top 25 collaborators of M.H. Breuning. A scholar is included among the top collaborators of M.H. Breuning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.H. Breuning. M.H. Breuning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saase, Jan L.C.M. van, et al.. (2015). Autosomal-Dominant Polycystic Kidney Disease and Hypertension: A Review. Contributions to nephrology. 97. 71–92.
2.
Hendriks, A.C., et al.. (2012). Prenatale screening in het licht van zelfbeschikking. Tijdschrift voor Gezondheidsrecht. 36(6). 463–474. 1 indexed citations
3.
Boertien, Wendy E., Esther Meijer, Debbie Zittema, et al.. (2012). Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease. Nephrology Dialysis Transplantation. 27(11). 4131–4137. 64 indexed citations
4.
Gijsbers, A.C.J., et al.. (2010). X-chromosome duplications in males with mental retardation: pathogenic or benign variants?. Clinical Genetics. 79(1). 71–78. 5 indexed citations
5.
Hannes, Femke, Andrew J. Sharp, Heather C. Mefford, et al.. (2008). Recurrent reciprocal deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variant. Journal of Medical Genetics. 46(4). 223–232. 207 indexed citations
6.
Kant, Sarina G., Floor K Grote, Minke H. de Ru, et al.. (2007). Radiographic Evaluation of Children with Growth Disorders. Hormone Research in Paediatrics. 68(6). 310–315. 19 indexed citations
7.
Nielsen, Maartje, Frederik J. Hes, Marjan M. Weiss, et al.. (2007). Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis. Clinical Genetics. 71(5). 427–433. 107 indexed citations
8.
White, Stefan J., Lisenka E.L.M. Vissers, Ad Geurts van Kessel, et al.. (2007). Variation of CNV distribution in five different ethnic populations. Cytogenetic and Genome Research. 118(1). 19–30. 43 indexed citations
9.
White, Stefan J., Annemieke Aartsma‐Rus, Kevin M. Flanigan, et al.. (2006). Duplications in theDMD gene. Human Mutation. 27(9). 938–945. 113 indexed citations
10.
Kant, Sarina G., Jan M. Wit, & M.H. Breuning. (2005). Genetic Analysis of Tall Stature. Hormone Research in Paediatrics. 64(3). 149–156. 9 indexed citations
11.
Hendriks, Yvonne, Jasper J. van der Smagt, Sarina G. Kant, et al.. (2003). Bannayan–Riley–Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive cases. Familial Cancer. 2(2). 79–85. 55 indexed citations
12.
Ginjaar, H.B., et al.. (2003). Somatic mosaicism of a point mutation in the dystrophin gene in a patient presenting with an asymmetrical muscle weakness and contractures. Neuromuscular Disorders. 13(4). 317–321. 7 indexed citations
13.
Breuning, M.H. & Esmée A. Bakker. (2000). [From gene to disease; marenostrine and familial Mediterranean fever].. PubMed. 144(36). 1728–30. 2 indexed citations
14.
Oberstein, Saskia A.J. Lesnik, Michel D. Ferrari, Egbert Bakker, et al.. (1999). Diagnostic Notch3 sequence analysis in CADASIL: Three new mutations in Dutch patients. Neurology. 52(9). 1913–1913. 63 indexed citations
15.
Breuning, M.H., et al.. (1997). Cross-Species Homology of the CLN3 Gene. Neuropediatrics. 28(1). 18–20. 18 indexed citations
16.
Giles, Rachel H., Fred Petrij, J. Wessels, et al.. (1997). Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16). Leukemia. 11(12). 2087–2096. 55 indexed citations
17.
18.
Smit, Vincent T.H.B.M., J.W. Wessels, P. Mollevanger, et al.. (1991). Improved interpretation of complex chromosomal rearrangements by combined GTG banding and in situ suppression hybridization using chromosome‐specific libraries and cosmid probes. Genes Chromosomes and Cancer. 3(4). 239–248. 29 indexed citations
19.
Gedeon, Ági K., John C. Mulley, & M.H. Breuning. (1989). XmnI,HincII andBclI RFLPs at D16S79. Nucleic Acids Research. 17(12). 4905–4905. 2 indexed citations
20.
Breuning, M.H., HG Brunner, Jasper J. Saris, et al.. (1987). IMPROVED EARLY DIAGNOSIS OF ADULT POLYCYSTIC KIDNEY DISEASE WITH FLANKING DNA MARKERS. The Lancet. 330(8572). 1359–1361. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026